Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC)

被引:53
|
作者
Nakagawa, T
Otake, Y
Yanagihara, K
Miyahara, R
Ishikawa, S
Fukushima, M
Wada, H
Tanaka, F
机构
[1] Kyoto Univ, Fac Med, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan
[2] Taiho Pharmaceut Co Ltd, Inst Appl Oncol, Hanno, Saitam 3578527, Japan
关键词
thymidylate synthase; non-small cell lung cancer; cell proliferation;
D O I
10.1016/j.lungcan.2003.09.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many experimental studies have revealed that enhanced thymidylate synthase (TS) expression is significantly correlated with higher proliferative activity of tumor cells, which may account for a poor prognosis of high-TS patients. However, only a few clinical studies have focused on the correlation between TS status and cell proliferation. Therefore, we assessed the correlation between TS expression and proliferative index (PI) as a marker of cell proliferation or p53 status in a total of 109 patients with completely resected pathologic stage I, non-small cell lung cancer (NSCLC). PI was defined as the percentage of tumor cells with positive staining against proliferative cell nuclear antigen (PCNA). The mean PIs of TS-high and TS-low tumors were 48.2% and 34.4% respectively, showing a significantly higher proliferative activity of TS-high tumor (P = 0.020); when stratified according to histological type, the difference was significant in adenocarcinoma (P = 0.038), but not in squamous cell carcinoma. There was no significant correlation between TS expression and p53 status. In conclusion, tumor cells with higher TS expression have higher proliferative activity in NSCLC, especially in adenocarcinoma. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 50 条
  • [1] Predictive significance of thymidylate synthase expression in non-small cell lung cancer (NSCLC)
    Dobra, J.
    Kulda, V.
    Pesta, M.
    Babuska, V.
    Pesek, M.
    Racek, J.
    FEBS JOURNAL, 2013, 280 : 319 - 319
  • [2] Expression of thymidylate synthase in human non-small cell lung cancer
    Otake, Y
    Tanaka, F
    Yanagihara, K
    Hitomi, S
    Okabe, H
    Fukushima, M
    Wada, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (11): : 1248 - 1253
  • [3] Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer
    Kulda, Vlastimil
    Hrda, Kristyna
    Houdek, Zbynek
    Dobra, Jana Kolaja
    Vrzakova, Radana
    Svaton, Martin
    Safranek, Jarmil
    Dolezal, Jan
    Babuska, Vaclav
    Pesek, Milos
    Topolcan, Ondrej
    Pesta, Martin
    ANTICANCER RESEARCH, 2017, 37 (12) : 6953 - 6958
  • [4] Thymidylate synthase inhibitors for non-small cell lung cancer
    Galvani, Elena
    Peters, Godefridus J.
    Giovannetti, Elisa
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1343 - 1356
  • [5] Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy
    Gandara, David R.
    Mack, Philip C.
    Omori, Akiko
    Grimminger, Peter
    Lara, Primo N.
    Joshi, Mary-Beth M.
    Harpole, David H.
    Danenberg, Kathleen D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S400 - S400
  • [6] Efficacy of Pemetrexed in Relapsed Non-Small Cell Lung Cancer and Thymidylate Synthase Expression
    Park, Choel-Kyu
    Kim, Kyu-Sik
    Oh, In -Jae
    Tseden-Ish, Manaljav
    Choi, Yoo-Duk
    Kwon, Yong-Soo
    Kim, Yoo-Il
    Lim, Sung-Chul
    Kim, Young-Chul
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 67 (03) : 191 - 198
  • [7] Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: Relationship between mRNA expression and activity
    Miyoshi, T
    Kondo, K
    Fujino, H
    Takahashi, Y
    Sawada, N
    Sakiyama, S
    Tsuyuguchi, M
    Kimura, S
    Sumitomo, M
    Monden, Y
    ANTICANCER RESEARCH, 2005, 25 (2A) : 923 - 930
  • [8] Thymidylate synthase (TS) gene expression in patients with ALK positive (+) non-small cell lung cancer (NSCLC): Implications for therapy
    Gandara, David R.
    Huang, Eric
    Desai, Sonal
    Mack, Philip C.
    Beckett, Laurel
    Stephens, Craig
    Zeger, Gary
    Danenberg, Kathleen D.
    Maus, Martin Karl Herbert
    Li, Tianhong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Baseline thymidylate synthase expression according to histological subtypes of non-small cell lung cancer
    Scagliotti, G.
    Monica, V.
    Ceppi, P.
    Righi, L.
    Cambieri, A.
    Volante, M.
    Novello, S.
    Cappelletto, E.
    Papotti, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer
    Kawabata, Shigeru
    Chiang, Chun-Te
    Tsurutani, Junji
    Shiga, Hideaki
    Arwood, Matthew L.
    Komiya, Takefumi
    Gills, Joell J.
    Memmott, Regan M.
    Dennis, Phillip A.
    ONCOTARGET, 2014, 5 (04) : 1062 - 1070